India's Pharmaceutical Exports

Country Profile

Kenya

Kenya is a major destination for Indian pharmaceutical exports — $427M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 73% of shipments, with vaccines contributing $44.4M. The compound annual growth rate since FY2015 stands at 4.8%.

🇰🇪 #12 Destination · $427M · 1.7× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$427M
Exports FY2025–26 DGCIS
1.7×
Growth FY2015→2026
1.4%
Share of India Total
#12
Rank Among 178 Markets
4.8%
CAGR FY2015→2026
Kenya is a major destination for Indian pharmaceutical exports — $427M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 73% of shipments, with vaccines contributing $44.4M. The compound annual growth rate since FY2015 stands at 4.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $312M (73.0%) Medicine Ingredients $58.9M (13.8%) Vaccines $44.4M (10.4%) Surgical & Hospital Supplies $7.14M (1.7%) Traditional & Herbal $4.73M (1.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Kenya in the RBI overseas direct investment dataset (2011–2026).